The global Contraceptive Drugs Market was pegged at $14.32 billion in 2019, and is anticipated to garner $24.42 billion by 2027, manifesting a CAGR of 6.9% from 2020 to 2027.
Key Takeaways:
The global contraceptive drugs market is expected to continue to grow, driven by factors such as increasing awareness of contraception, rising demand for family planning services, and technological advancements.
Combination oral contraceptives (COCs) remain the most popular type of contraceptive drugs, accounting for the majority of the market share.
Other types of contraceptive drugs, such as injectables, transdermal patches, and intrauterine devices (IUDs), are also gaining popularity due to their ease of use and efficacy.
North America and Europe are the largest markets for contraceptive drugs, but the Asia-Pacific region is expected to experience the highest growth in the coming years, driven by increasing population, rising awareness, and government initiatives to promote family planning.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/9850
Competitive Landscape
- Bayer AG
- Pfizer Inc.
- Merck & Co., Inc.
- Allergan plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- HLL Lifecare Limited
- Piramal Enterprises Ltd.
- Cipla Inc.
- Lupin Pharmaceuticals, Inc.
Market Segmentation
Product Type: This includes combination oral contraceptives (COCs), progestin-only pills (POPs), injectables, transdermal patches, vaginal rings, intrauterine devices (IUDs), and implants.
Distribution Channel: This includes retail pharmacies, hospitals, clinics, and e-commerce.
End User: This includes women and men.
Geography: This includes North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Hormonal Vs. Non-hormonal: This includes hormonal contraceptive drugs that contain synthetic hormones and non-hormonal contraceptive drugs that do not contain hormones.
Prescription Vs. Over-the-Counter (OTC): This includes prescription drugs that require a doctor’s prescription and OTC drugs that can be purchased without a prescription.
Request for Customization:
https://www.alliedmarketresearch.com/request-for-customization/9850
Recent developments:
New Product Launches: Several new contraceptive drugs have been launched in the market in recent years. For instance, in 2021, the FDA approved Slynd, a new progestin-only oral contraceptive pill. In 2020, the FDA also approved Twirla, a new transdermal contraceptive patch.
Non-Hormonal Options: Non-hormonal contraceptive options are gaining popularity in the market due to concerns over the potential side effects of hormonal contraceptives. In 2019, the FDA approved the first non-hormonal contraceptive gel, Phexxi, which works by changing the acidity of the vagina to prevent sperm from reaching the egg.
Expansion of Distribution Channels: Companies are expanding their distribution networks to reach more customers. For instance, in 2020, HLL Lifecare Limited, a government-owned company in India, launched a new e-commerce platform to sell its contraceptive products.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/9850
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
Browse more latest healthcare reports:
Heat Therapy Market by Type (Over The Counter (OTC) Devices, Prescription-Based Devices), by Application (Musculoskeletal Disorder, Chronic and Post-Operative Pain Management, Injury, Others), by End User (Hospitals, Physiotherapy Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
AI in Genomics Market by Offering (Hardware, Software, Services), by Technology (Machine Learning, Computer Vision), by Application (Drug Discovery and Development, Precision Medicine, Diagnostics, Others), by End User (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com